Form D · Biotechnology
Climb Bio, Inc.
Wellesley Hills, MA · CIK 0001768446
Offering snapshot reported May 4, 2026 · SEC filing
- Reported sold
- $110M Offering amount: $110M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2026 | Initial | $110,076,289 | No comparison | 22 | SEC filing |
| Jul 2, 2024 | Initial | $119,999,986 | No comparison | 8 | SEC filing |
| Jul 2, 2024 | Initial | $41,867,154 | No comparison | 6 | SEC filing |
| May 28, 2021 | Initial | $59,999,987 | No comparison | 9 | SEC filing |
| Nov 3, 2020 | Initial | $4,999,995 | No comparison | 4 | SEC filing |
| Oct 23, 2019 | Amendment | $16,302,501 | $4,062,501vs Feb 19, 2019 | 6 | SEC filing |
| Oct 23, 2019 | Initial | $9,999,997 | No comparison | 1 | SEC filing |
| Feb 19, 2019 | Initial | $12,240,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $6.3M
- Finders' fees
- $0
- Form D file number
- 021-582793
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 | |
| Piper Sandler and Co. | 665 | |
| Raymond James & Associates, Inc. | 705 | |
| BTIG, LLC | 122225 | |
| Robert W. Baird & Co. Incorporated | 8158 | |
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed May 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Susan Altschuller | Executive |
| Robert Azelby | Director, Executive |
| Aoife Brennan | Director, Executive |
| James Bucher | Executive |
| Alexander (Bo) Combo | Director |
| Kimberlee Drapkin | Director |
| Judith Dunn | Director |
| David Alexandre Gros | Director |
| Erin Lavelle | Executive |
| Andrew Levin | Director |
| Valerie Morisset | Executive |
| Leone Patterson | Director |
| Liam Ratcliffe | Director |
| Adam Rosenberg | Director |
| Harald Stock | Director |
| Simon Tate | Director |
| Stephen Thomas | Director |
| Julio Vega | Executive |
| Douglas Williams | Director |
| Perrin Wilson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20 William Street Suite 145
Wellesley Hills, MA, 02481
Wellesley Hills, MA, 02481